View in EDS HTML Full Text PDF Full Text

Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.

Saved in:
Bibliographic Details
Title: Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.
Authors: Jeon YH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Lee N; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea., Yoo J; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Won S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Shin SK; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Kim KH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea., Park JG; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea., Kim MG; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Kim HR; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Oh K; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea., Lee DS; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
Source: Biomedicines [Biomedicines] 2022 Mar 30; Vol. 10 (4). Date of Electronic Publication: 2022 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35453555
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8<superscript>+</superscript> T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jeon+YH%22">Jeon YH</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+N%22">Lee N</searchLink>; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea.<br /><searchLink fieldCode="AU" term="%22Yoo+J%22">Yoo J</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.<br /><searchLink fieldCode="AU" term="%22Won+S%22">Won S</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.<br /><searchLink fieldCode="AU" term="%22Shin+SK%22">Shin SK</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+KH%22">Kim KH</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Park+JG%22">Park JG</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+MG%22">Kim MG</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HR%22">Kim HR</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.<br /><searchLink fieldCode="AU" term="%22Oh+K%22">Oh K</searchLink>; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+DS%22">Lee DS</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101691304%22">Biomedicines</searchLink> [Biomedicines] 2022 Mar 30; Vol. 10 (4). <i>Date of Electronic Publication: </i>2022 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101691304 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2227-9059 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222279059%22">22279059 </searchLink><i>NLM ISO Abbreviation: </i>Biomedicines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35453555
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/biomedicines10040805
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeon YH
      – PersonEntity:
          Name:
            NameFull: Lee N
      – PersonEntity:
          Name:
            NameFull: Yoo J
      – PersonEntity:
          Name:
            NameFull: Won S
      – PersonEntity:
          Name:
            NameFull: Shin SK
      – PersonEntity:
          Name:
            NameFull: Kim KH
      – PersonEntity:
          Name:
            NameFull: Park JG
      – PersonEntity:
          Name:
            NameFull: Kim MG
      – PersonEntity:
          Name:
            NameFull: Kim HR
      – PersonEntity:
          Name:
            NameFull: Oh K
      – PersonEntity:
          Name:
            NameFull: Lee DS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 03
              Text: 2022 Mar 30
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2227-9059
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Biomedicines
              Type: main
ResultId 1